A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India

Authors
Category Primary study
JournalCancer Informatics
Year 2023
This article has no abstract
Epistemonikos ID: 22b7d0a62f31c4f60aa685f982b7b3fa07763c17
First added on: Feb 16, 2025